Viewing Study NCT06398457


Ignite Creation Date: 2025-12-24 @ 6:57 PM
Ignite Modification Date: 2026-01-31 @ 12:50 PM
Study NCT ID: NCT06398457
Status: RECRUITING
Last Update Posted: 2025-09-26
First Post: 2024-05-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
Sponsor:
Organization: